Clinical Manifestations and Molecular Diagnosis of Scrub Typhus and Murine Typhus, Vietnam, 2015-2017.
The extent and severity of disease associated with scrub and murine typhus in Vietnam is unknown because both clinical- and laboratory-based diagnostics are limited and no systematic surveillance programs or reporting systems are in place (7). Frequent cases of scrub typhus and murine typhus were reported among US military personnel stationed in Vietnam during the 1970s (6-8). Cases also have been identified among returning travelers from the region (9,10). One recent study demonstrated that patients with acute undifferentiated fever admitted to a large referral hospital in Hanoi were often infected with scrub typhus (40.9%) and murine typhus (33.3%) (11). A previous study in the same hospital showed that scrub typhus accounted for 3.5% (251/7,226) of all admissions and 33.5% (251/749) of clinical admissions that met the clinical criteria for testing to the infectious diseases department (12). Another clinical study conducted in central Vietnam reported the use of eschar swabbing for molecular diagnosis and genotyping of O. tsutsugamushi, which appeared helpful for rapid case detection in the early stage of infection (13). Together, these findings strongly suggest that rickettsioses are common causes of acute fever in Vietnam that are often underdiagnosed and undertreated.
We conducted a prospective hospital-based study of clinically suspected rickettsiosis in the National Hospital for Tropical Diseases (NHTD) and Bach Mai Hospital, 2 large tertiary-care referral hospitals in Hanoi, during 2015-2017. We describe the clinical characteristics of the cases and the assessment of molecular testing results for diagnosing scrub typhus and murine typhus.
We conducted a prospective observational study of clinically suspected rickettsioses at NHTD and Bach Mai Hospital. We included patients [greater than or equal to] 15 years of age with fever (temperature >37.5[degrees]C) of unknown cause or presence of [greater than or equal to] 1 eschar and [greater than or equal to] 1 of the following clinical symptoms: rash, headache, myalgia, lymphadenopathy, hepatomegaly, or splenomegaly. We excluded patients with laboratory-confirmed malaria, dengue, measles, or influenza (via blood smear or rapid tests); patients with clinically and radiologically confirmed pneumonia; and patients with microbiologically confirmed sepsis or urinary tract infection.
We recorded information regarding patient demographics, medical history, clinical and laboratory findings, and treatment in a case record form. We classified outcome at discharge as full recovery, death, or palliative discharge. Palliative discharge is a commonly preferred alternative to dying in the hospital in Vietnam, where a patient for whom ongoing care is considered futile is discharged to permit them to die in their home with their family.
We obtained written informed consent from patients [greater than or equal to] 18 years of age and from patients and their parents or guardians for those 15-17 years of age enrolled at admission. The study protocol was approved by the institutional review boards of NHTD (document no. 01A/HDDD-NDTU) and Bach Mai Hospital (document no. 6/BM-HDDD).
Specimen Collection and Laboratory Testing
Blood was drawn from all patients at admission for blood culture and basic laboratory tests. These tests included complete blood counts, biochemistry, procalcitonin, and serologic and molecular testing for rickettsioses.
We screened serum samples at 1:100 dilution and considered net optical density of >0.5 positive, as described (14,15). ELISA antigen preparations were derived from R. typhi Wilmington for TGR-specific IgG, R. conorii Malish 7 for SFGR-specific IgG, and O. tsutsugamushi Karp, Kato, and Gilliam for the detection of STGO-specific IgG.
Quantitative Real-Time PCR
We collected whole blood in EDTA tubes, then processed it with Ficoll-Paque to obtain leukocyte buffy coats. We extracted DNA from the buffy coats using QIAamp DNA Mini Kits (QIAGEN, https://www.qiagen.com) according to the manufacturer's instructions and previously described assays (16-19). Diagnosis of scrub typhus was based on species-specific quantitative real-time PCRs (qPCRs) targeting the corresponding 47-kDa outer membrane protein gene of O. tsutsugamushi (Otsu47) and murine typhus was diagnosed based on the outer membrane protein B gene of Rickettsia typhi (Rtyph). When both species-specific assays were negative but the genus-specific qPCR assay targeting the 17-kDa antigen gene (Rick17b) was positive, we classified the diagnoses as nonscrub typhus-nonmurine typhus rickettsiosis. We initially tested all buffy coat samples in this study with the Otsu47 qPCR assay to detect O. tsutsugamushi. We subsequently assessed Otsu47-negative samples with the genus-specific qPCR assay Rick17b to detect Rickettsia spp. We subsequently tested Rick17b-positive samples with the Rtyph qPCR. For each qPCR, we extracted 1 [micro]L of nucleic acid from the buffy coats and added it to a final reaction volume of 25 [micro]L, using Platinum Quantitative PCR SuperMix-UDG (Invitrogen, https://www. thermofisher.com), and performed real-time PCR on an Applied Biosystems 7500 Fast Real-Time PCR System (Applied Biosystems, https://www.appliedbiosystems.com).
We summarized categorical variables as frequencies and percentages and used the Fisher exact test to compare clinical characteristics among different groups. We summarized non-normally distributed continuous variables as medians with interquartile ranges (IQRs) and compared them using the Mann-Whitney test. We summarized data following normal distribution as means with SDs and compared them using the analysis of variance test for 2-group comparisons. To investigate whether cases from outside the province of Hanoi were biased toward higher severity, we tested the differences in symptoms between Hanoi and the other provinces using the Fisher exact test, with Benjamini and Hochberg correction for multiple comparisons (20). We performed analyses using Stata 12.0 (StataCorp LLC, https://www.stata.com).
Patient Population and Enrollment
We enrolled 310 persons with suspected rickettsiosis cases during March 2015-March 2017. Eight cases were excluded because diagnostic assays showed positive results for other infections (Figure 1). The median age of the final study population (n = 302) was 50 years (IQR 36-60); 158 (52.3%) were men and 144 (47.7%) women. The 302 patients originated from 28 northern provinces. The largest proportion came from the provinces of Hanoi (122, 40.4%), Phu Tho (28, 9.3%), and Hung Yen (17, 5.6%) (Figure 2). Ninety-seven (32.1%) patients were admitted directly from the community to the study hospitals and 205 (67.9%) were referred from other hospitals. Of the 205 transferred patients, 134 (65.4%) were from hospitals outside Hanoi (Table 1). Symptoms did not differ between those admitted in Hanoi and those transferred from other provinces (Table 2).
Of the 302 patients, 171 (56.6%) reported living in rural areas; 127 (42.1%) also reported that they were farmers. During the study, 224 (74.2%) patients were admitted to the hospital in the summer (April-August), with the highest number (61, 20.2%) in the month of May (Figure 3). The median delay in the time from onset of symptoms to treatment was 9 days (range 6-11 days). Eight patients were admitted to the study [greater than or equal to] 30 days after onset of symptoms, 1 of whom was admitted 41 days after symptoms began; all 8 were successfully treated. Furthermore, 83 (27.5%) patients reported use of antimicrobial drugs before initial admission to the hospital, although the identity of these drugs was not given.
We assessed admission serum samples for IgG against STGO, TGR, and SFGR using ELISAs in a subset of 121 of the 302 enrolled patients. Of these, 6 (5.0%) were ELISA positive for STGO IgG, 2 (1.7%) were positive for TGR IgG, and 1 (0.8%) was positive for SFGR IgG. One serum sample was positive for IgG in TGR and SFGR ELISAs. For 6 samples positive by STGO ELISA, 4 also were positive for O. tsutsugamushi by Otsu47 qPCR, whereas 20 Otsu47-positive samples were STGO ELISA negative.
Of 302 enrolled patients, 103 (34.1%) had qPCR-confirmed scrub typhus, 12 (4.0%) had qPCR-confirmed murine typhus, and 2 (0.7%) cases could not be diagnosed beyond genus-specific Rick17b qPCR positive (i.e., Rickettsia spp.). Thirty-five patients (11.6%) were qPCR-negative but had eschars.
Table 3 gives demographic data, clinical features, and laboratory findings for 115 patients with confirmed scrub typhus (n = 103) and murine typhus (n = 12). There was no major difference in the mean age between these 2 groups, but we did note differences in the geographic distribution of each group. Of the 103 scrub typhus cases, the highest proportion were from Hanoi Province (34, 33.0%), Hai Duong (10, 9.7%), and Phu Tho (10, 9.7%). Most scrub typhus patients reported rural residence (66, 64.1%). Among 34 scrub typhus patients from Hanoi Province, 19 (55.9%) reported living in rural areas. More men (n = 10) than women (n = 2) had murine typhus; most lived in Hanoi Province (10, 83.3%) and were from urban areas (8, 66.7%). Farming was the most common occupation reported among both groups, 52 (50.5%) for scrub typhus patients and 5 (41.7%) for murine typhus patients.
Patients with confirmed rickettsial disease frequently reported headache, myalgia, and skin hyperaemia (<78.6% for scrub typhus patients and 91.7% for murine typhus patients). Other symptoms, such as rash, sore throat, cough, nausea, vomiting, abdominal pain, diarrhea, dizziness, lymphadenopathy, hepatomegaly, splenomegaly, and edema, were less frequent in all groups. All cases with lymphadenopathy (n = 19) were confirmed to be scrub typhus.
The most common clinical features among 103 confirmed scrub typhus patients, other than fever, were headache (81, 78.6%), myalgia (73, 70.9%), skin hyperaemia (82, 79.6%), and conjunctivitis (66, 64.1%). Rash was seen in only 34.0% (35) of scrub typhus patients, lymphodenopathy in 18.6% (19), and hepatomegaly in 9.7% (10). Complications in scrub typhus patients were common and included altered mental status (10, 9.7%), jaundice or hyperbilirubinemia (24, 40%), and pulmonary pathology (rales) (22, 21.4%). Eschars were found in 53.4% (55) of scrub typhus cases, whereas eschars were not observed in murine typhus cases. Most scrub typhus and murine typhus patients had elevated liver aminotransferases, creatinine, procalcitonin, C-reactive protein, and bilirubin (Table 3). We found no differences in the clinical or laboratory findings between patients with confirmed murine typhus and scrub typhus, though it is noteworthy that no patients with murine typhus had lymphadenopathy.
Patients did not immediately seek treatment, which delayed time from the onset of symptoms to treatment to a median of 9 days (IQR 7-11) for scrub typhus patients and 8.5 days (IQR 5-10) for murine typhus patients. After beginning treatment, 49.2% (31/63) of scrub typhus patients and 60% (6/10) of murine typhus patients were afebrile in <72 h. Average lengths of hospital stays were 7 days (IQR 5-10) for scrub typhus patients and 8 days (IQR 7-8.5) for murine typhus patients. Doxycycline was used to treat 89.2% (91/102) of scrub typhus patients and 91.7% (11/12) of murine typhus patients, and 30 patients (28 with scrub typhus and 2 with murine typhus) were treated with doxycycline plus chloramphenicol. All patients treated with antimicrobial drugs were afebrile within 3-5 days after beginning treatment, [less than or equal to] 3 days for murine typhus and [less than or equal to] 4 days for scrub typhus patients, and all recovered.
Five deaths due to scrub typhus are reported in this study. One patient died in the hospital, and the other 4 patients were discharged from the hospital with a serious medical condition at the request of their family members and died shortly after being discharged. Three (60%) of these patients were [greater than or equal to] 60 years of age, and all 5 experienced respiratory failure, hypotension, cardiovascular compromise, elevated aminotransferase levels, coagulation disorder during hospitalization, and markedly elevated serum ferritin levels (>1,500 [micro]g/mL). One also had elevated lactate dehydrogenase (>1,000 U/L). Lung infiltrations and consolidation were the most common imaging findings. All 5 deaths were due to delay in time to appropriate care.
Of the 185 patients with suspected rickettsial disease who tested negative by molecular methods (qPCR-), 35 had eschar (eschar+) and 150 did not (eschar-). We noted several significant differences when comparing the demographic data, clinical symptoms, and laboratory results between these 2 groups with unknown etiology (Appendix Table 1, http://wwwnc.cdc.gov/EID/article/25/4/18-0691Techapp1.pdf). However, when the eschar+/qPCR- group with unknown etiology (n = 35) was compared to the scrub typhus qPCR+ group (n = 103), they were found to be similar for all but 2 categories (Appendix Table 2). By definition, 1 difference was that the eschar+/qPCR- group was characterized by having an eschar and many individuals in the other group did not. The second difference was that the eschar+/qPCR- group was more likely to have been treated with antimicrobial drugs before enrollment in this study than the qPCR+ group. Treatment with antimicrobial drugs is known to rapidly decrease the levels of rickettsial bacteria below detectable levels in blood, which may explain why qPCR results were negative in the eschar+ patients. Moreover, the comparison of the scrub typhus group to the group with unknown etiology that was eschar-/qPCR-showed many significant differences and therefore likely represents diverse etiologies (Appendix Table 3). Collectively, these results indicate that the presence of eschar is an important sign for the diagnosis of scrub typhus in northern Vietnam.
This study contributes to accumulating evidence that rickettsial diseases are a common cause of fever in hospitalized patients in northern Vietnam and suggests a predominance of scrub typhus and a lower prevalence for murine typhus. Of the 302 patients with suspected rickettsial disease we enrolled, we diagnosed scrub typhus in 103 (34.1%) and murine typhus in 12 (4.0%). Rickettsioses peaked during the summer rainy season, when vector populations (e.g., ticks, fleas, and trombiculid mites) are most abundant and active and workers are in the rice fields. Previous studies have similarly reported seasonality that corresponds to summer months and rice harvesting (11,12).
Among a subset of 121 patients with suspected rickettsiosis whose serum samples were tested, 6 (5.0%) showed prevalence of STGO IgG, 2 (1.7%) TGR IgG, and 1 (0.8%) SFGR IgG. This finding differs from what we previously reported for the prevalence of IgG against STGO (1.1%, 10/908), TGR (6.5%, 58/908), and SFGR (1.7%, 15/908) among healthy persons in the rural BaVi District and an urban area of Hanoi using the same ELISAs described here (15). In our previous study, 40% of participants were <20 years of age (15). In contrast, the patients investigated here were older. Scrub typhus incidence has been reported to peak in the fifth decade of life (12), with highest observed prevalence in adults 61-80 years of age (21). Thus, it is not surprising that the average age of qPCR+ scrub typhus cases and eschar+/qPCR- cases in this study was 50.3 years (Appendix Table 3). Note that our seroprevalence is lower than that described for suburban Bangkok, Thailand, and urban and rural Malang, Indonesia (21).
Of note, 4 of 6 qPCR-positive patients had IgG-positive acute-phase serum samples. The positive ELISA results did not appear to be associated with duration of fever before acute-phase blood collection. Two of the samples came from patients with fever of 5 days' duration, suggesting they may have had preexisting O. tsutsugamushi-specific IgG. For 2 patients with onset of symptoms at 8 and 10 days, IgG positivity could have been due to the current infection, a previous infection, or both (22,23). We analyzed acute-phase serum samples for 20 Otsu47-positive samples, and all were negative by STGO ELISA. These examples highlight the importance of collecting paired acuteand convalescent-phase samples at least 14 days apart to serologically confirm the diagnosis of scrub typhus (23).
Our study showed a high proportion of eschars among scrub typhus patients (53.4%), and presence of eschar, a well-known clinical sign for scrub typhus (13), was 1 consideration used for defining suspect cases. The proportion of patients with eschar among our study population was similar to reports from northern (56.2%) and central (62.9%) Vietnam and from Laos and South Korea (11,13,24). The proportion of eschars among scrub typhus patients appears variable and has been reported at [less than or equal to] 7% in children from Thailand (25). We did not recruit young children in this study, which may explain the higher proportion of scrub typhus patients with eschar reported here.
A recent study conducted in Quang Nam Province in central Vietnam demonstrated that the presence of eschar was the chief diagnostic indicator for scrub typhus (13). In that study, the authors used qPCR assays on DNA extracted from swab samples of patients' eschar to identify scrub typhus. They recommended that eschar qPCR should be routinely considered for rickettsial diagnosis in the early phase of infection because it is easy to perform and has a high positive predictive value (13).
We identified 35 patients with an eschar and clinical symptoms consistent with scrub typhus but who tested negative for O. tsutsugamushi by qPCR on blood samples. These patients may have had true scrub typhus or spotted fever cases, despite the negative qPCR results. The sensitivity of qPCR for blood may have been inadequate to detect the small number of bacteria present, especially after antimicrobial therapy was commenced (26). Rickettsial DNA is known to disappear quickly from blood after start of appropriate antimicrobial drug therapy. The sensitivity of qPCR on eschar swabs has been reported as higher than for blood samples (18/20 eschar swabs were positive by qPCR vs. 5/20 blood samples from same patients ), at 85%-86% with specificity of 100% (13,27). The presence of rickettsiae in eschar and rash samples is not affected by previous antimicrobial drug treatment (23). Thus, for qPCR, the specimen of choice for eschar- or rash-producing rickettsioses is a swab (eschars) or biopsy (eschar or rash) (23).
In our study population, the most common symptoms among qPCR-positive patients included fever, headache, myalgia, conjunctivitis, and rash. Some patients also experienced cough, vomiting, nausea, abdominal pain, lymphadenopathy, hepatomegaly, and splenomegaly. Patients with scrub typhus had a higher frequency of lymphadenopathy, a well-known clinical sign of scrub typhus (28). Headache is frequent with other illnesses, and other studies also have found that clinical characteristics often are not helpful in identifying rickettsial infections. We also saw a high proportion of scrub typhus patients with conjunctivitis and rash in our study. Rash is a typical finding among patients suspected of having rickettsiosis and was among the inclusion criteria for our study. Rash is reported in [approximately equal to] 45%-50% of patients with scrub typhus (29,30). However, its frequency varies between areas, as seen in Japan (93%), Thailand (7%), and India (1.7%) (31-33). A few studies conducted in central Vietnam reported that the proportion of scrub typhus patients with rash was low (3 1.2%) or absent, as in a study in central Vietnam (13). Rash may be difficult to diagnose in patients with relatively dark skin, or may be absent at time of examination in the hospital. Most scrub typhus patients had fever for >7 days, time in which rash may have disappeared. We found no major differences in clinical manifestations between patients from Hanoi Province and other provinces of northern Vietnam, suggesting an absence of bias toward higher severity among patients traveling far to the hospital.
Complications of scrub typhus include jaundice, meningoencephalitis, myocarditis, acute respiratory distress, and renal failure (34,35). When treatment is delayed or does not include appropriate antimicrobial drugs, case-fatality rates are up to 6.0% but can be up to 70% (29). Our fatality rate of 4.9% (5/103) is similar to that in previous reports (12).
Murine typhus is a more challenging disease to diagnose clinically than scrub typhus because symptoms are nonspecific. The low number (n = 12) of confirmed murine typhus cases in our study makes it difficult to compare murine typhus with scrub typhus and other rickettsial diseases. However, patients with murine typhus experienced myalgia, conjunctivitis, nausea, cough, and vomiting less frequently than patients with scrub typhus, and no lymphadenopathy or eschars were described, which counters previous reports (11). Consistent with other reports, however, murine typhus was associated with elevated liver enzymes, procalcitonin, and C-reactive protein (11,36). These clinical findings may be useful for distinguishing the 2 diseases in areas where both are common (24).
Most scrub typhus and murine typhus patients in our study were treated with doxycycline, the recommended treatment for all ages. Chloramphenicol was used in severe cases as an additional drug. Within 72 hours of starting antimicrobial drug therapy, 49.2% (31/63) of scrub typhus and 60% (6/10) of murine typhus patients were afebrile. These data align with other reports (11). Rapid clinical improvement after using effective antimicrobial drugs is reported to back up clinical diagnoses of rickettsioses (37-39).
This study determined that scrub typhus was the predominant rickettsial disease diagnosed among patients hospitalized with acute undifferentiated fever in northern Vietnam. Public health awareness of scrub typhus and other rickettsial diseases in Vietnam should be enhanced to ensure healthcare providers can diagnose and treat these diseases successfully.
In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)[TM]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
All other clinicians completing this activity will be issued a certificate of participation. To participate in this journal CME activity: (1) review the learning objectives and author disclosures; (2) study the education content; (3) take the post-test with a 75% minimum passing score and complete the evaluation at http://www.medscape.org/journal/eid; and (4) view/print certificate. For CME questions, see page 848.
Release date: March 18, 2019; Expiration date: March 18, 2020
Upon completion of this activity, participants will be able to:
* Describe the epidemiological features of scrub typhus and murine typhus in northern Vietnam, according to a prospective, hospital-based study at 2 national referral hospitals in Hanoi
* Determine the clinical characteristics of scrub typhus and murine typhus in northern Vietnam, according to a prospective, hospital-based study at 2 national referral hospitals in Hanoi
* Explain laboratory findings of scrub typhus and murine typhus in northern Vietnam, according to a prospective, hospital-based study at 2 national referral hospitals in Hanoi
Amy J. Guinn, BA, MA, Copyeditor, Emerging Infectious Diseases. Disclosure: Amy J. Guinn, BA, MA, has disclosed no relevant financial relationships.
Laurie Barclay, MD, freelance writer and reviewer, Medscape, LLC. Disclosure: Laurie Barclay, MD, has disclosed no relevant financial relationships.
Disclosures: Nguyen Vu Trung, PhD; Le Thi Hoi, PhD; Vu Minh Dien, MD; Dang Thi Huong, MD; Tran Mai Hoa, BS; Vu Ngoc Lien, BS; Phan Van Luan, MSc; Sonia Odette Lewycka, PhD; Marc Choisy, PhD; Juliet E. Bryant, PhD; Behzad Nadjm, MBChB, MD; Allen L. Richards, PhD; and Nguyen Van Kinh, MD, PhD, have disclosed no relevant financial relationships. H. Rogier van Doorn, MD, PhD, has disclosed the following relevant financial relationships: received grants for clinical research from Pfizer Independent Grants for Learning & Change.
Earning CME Credit
To obtain credit, you should first read the journal article. After reading the article, you should be able to answer the following, related, multiple-choice questions. To complete the questions (with a minimum 75% passing score) and earn continuing medical education (CME) credit, please go to http://www.medscape.org/journal/eid. Credit cannot be obtained for tests completed on paper, although you may use the worksheet below to keep a record of your answers.
You must be a registered user on http://www.medscape.org. If you are not registered on http://www.medscape.org, please click on the "Register" link on the right hand side of the website.
Only one answer is correct for each question. Once you successfully answer all post-test questions, you will be able to view and/or print your certificate. For questions regarding this activity, contact the accredited provider, CME@medscape.net. For technical assistance, contact CME@medscape.net. American Medical Association's Physician's Recognition Award (AMA PRA) credits are accepted in the US as evidence of participation in CME activities. For further information on this award, please go to https://www.ama-assn.org. The AMA has determined that physicians not licensed in the US who participate in this CME activity are eligible for AMA PRA Category 1 Credits[TM]. Through agreements that the AMA has made with agencies in some countries, AMA PRA credit may be acceptable as evidence of participation in CME activities. If you are not licensed in the US, please complete the questions online, print the AMA PRA CME credit certificate, and present it to your national medical association for review.
1. You are advising a hospital in Hanoi, Vietnam, regarding anticipated needs for management of rickettsioses. According to the prospective, hospital-based study at 2 national referral hospitals in Hanoi by Trung and colleagues, which of the following statements about the epidemiological features of scrub typhus and murine typhus in northern Vietnam from 2015 to 2017 is correct?
A. Murine typhus was the predominant rickettsial disease diagnosed among hospitalized patients with acute undifferentiated fever in northern Vietnam
B. Scrub typhus was confirmed in 5.5% of patients
C. Rickettsioses peaked during the summer rainy season when vector populations are most abundant and active
D. Average age of quantitative PCR (qPCR) (+) scrub typhus cases and eschar (+)-qPCR (-) cases in this study was 20.3 years
2. According to the prospective, hospital-based study at 2 national referral hospitals in Hanoi by Trung and colleagues, which of the following statements about the clinical characteristics of scrub typhus and murine typhus in northern Vietnam is correct?
A. 20% of patients with scrub typhus had eschars
B. Cough, vomiting, and diarrhea were the most common symptoms among patients with qPCR positivity
C. Patients with murine typhus had a higher frequency of lymphadenopathy
D. Complications of scrub typhus include jaundice, meningoencephalitis, myocarditis, acute respiratory distress syndrome, and renal failure; case-fatality rate was 4.9%
3. According to the prospective, hospital-based study at 2 national referral hospitals in Hanoi by Trung and colleagues, which of the following statements about laboratory findings of scrub typhus and murine typhus in northern Vietnam is correct?
A. Prevalence of IgG against scrub typhus orientiae (STGO), typhus group rickettsiae (TGR), and spotted fever group rickettsiae (SFGR) among patients with suspected rickettsiosis was 5.0%, 1.7%, and 0.8%, respectively
B. Prevalence of IgG against STGO, TGR, and SFGR in this study was highly similar to that previously reported among healthy persons in a rural and urban area of Hanoi
C. Liver function test results were elevated in patients with scrub typhus but not in patients with murine typhus
D. The diagnosis of scrub typhus can be serologically confirmed using only acute samples
We thank all patients for their participation in this study. We are indebted to all nurses, physicians, and laboratory staff at the National Hospital for Tropical Diseases and Bach Mai Hospital who provided care for the patients, helped collect clinical data, and performed serological and molecular tests. We are grateful to our colleagues from the US Naval Medical Research Center for kindly providing training and technical assistance to establish serological and molecular testing capacity for rickettsial infections at the National Hospital for Tropical Diseases.
This study was supported by the National Foundation for Science and Technology Development of Vietnam [106-YS.042014.10] and was partially supported by the Defense Threat Reduction Agency, work unit #A1266 (A.L.R.) and the Wellcome Trust of Great Britain #106680/Z/14/Z (S.O.L., B.N., M.C., J.E.B., H.R.vD.)
Dr. Trung is an associate professor of the National Hospital for Tropical Diseases and Hanoi Medical University, Hanoi, Vietnam. His primary research interests include bacterial and viral identification by molecular diagnosis.
(1.) Ericson CD, Jensenius M, Fournier PE, Raoult D. Rickettsioses and the international traveler. Clin Infect Dis. 2004;39:1493-9. http://dx.doi.org/10.1086/425365
(2.) Blanton LS, Dumler JS, Walker DH. Rickettsia typhi (murine typhus). In: Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Inc.; 2014. p. 2221-4.e2.
(3.) Day NPJ, Newton PN. Scrub typhus and other tropical rickettsioses. In: Cohen J, Powderly WG, Opal SM, eds. Infectious diseases. 4th ed. Amsterdam: Elsevier Inc.; 2017. p. 1091-1097.e1.
(4.) Duong V, Mai TT, Blasdell K, Lo V, Morvan C, Lay S, et al. Molecular epidemiology of Orientia tsutsugamushi in Cambodia and Central Vietnam reveals a broad region-wide genetic diversity. Infect Genet Evol. 2013;15:35-42. http://dx.doi.org/10.1016/ j.meegid.2011.01.004
(5.) Liu D. Rickettsia. In: Tang Y-W, Sussman M, Dongyou L, Poxton I, Schwartzman J, eds. Molecular medical microbiology. 2nd ed. Boston: Academic Press; 2015. p. 2043-2056.
(6.) Miller MB, Bratton JL, Hunt J, Blankenship R, Lohr DC, Reynolds RD. Murine typhus in Vietnam. Mil Med. 1974;139: 184-6. http://dx.doi.org/10.1093/milmed/139.3.184
(7.) Lim C, Paris DH, Blacksell SD, Laongnualpanich A, Kantipong P, Chierakul W, et al. How to determine the accuracy of an alternative diagnostic test when it is actually better than the reference tests: A re-evaluation of diagnostic tests for scrub typhus using Bayesian LCMs. PLoS One. 2015;10:e0114930. http://dx.doi.org/10.1371/ journal.pone.0114930
(8.) Berman SJ, Kundin WD. Scrub typhus in South Vietnam. A study of 87 cases. Ann Intern Med. 1973;79:26-30. http://dx.doi.org/10.7326/0003-4819-79-1-26
(9.) Aung AK, Spelman DW, Murray RJ, Graves S. Rickettsial infections in Southeast Asia: implications for local populace and febrile returned travelers. Am J Trop Med Hyg. 2014;91:451-60. http://dx.doi.org/10.4269/ajtmh.14-0191
(10.) Azuma M, Nishioka Y, Ogawa M, Takasaki T, Sone S, Uchiyama T. Murine typhus from Vietnam, imported into Japan. Emerg Infect Dis. 2006;12:1466-8. http://dx.doi.org/10.3201/ eid1209.060071
(11.) Hamaguchi S, Cuong NC, Tra DT, Doan YH, Shimizu K, Tuan NQ, et al. Clinical and epidemiological characteristics of scrub typhus and murine typhus among hospitalized patients with acute undifferentiated fever in Northern Vietnam. Am J Trop Med Hyg. 2015;92:972-8. http://dx.doi.org/10.4269/ajtmh.14-0806
(12.) Nadjm B, Thuy PT, Trang VD, Dang Ha L, Kinh NV, Wertheim HF. Scrub typhus in the northern provinces of Vietnam: an observational study of admissions to a national referral hospital. Trans R Soc Trop Med Hyg. 2014;108:739-40. http://dx.doi.org/ 10.1093/trstmh/tru145
(13.) Le Viet N, Laroche M, Thi Pham HL, Viet NL, Mediannikov O, Raoult D, et al. Use of eschar swabbing for the molecular diagnosis and genotyping of Orientia tsutsugamushi causing scrub typhus in Quang Nam province, Vietnam. PLoS Negl Trop Dis. 2017;11:e0005397. http://dx.doi.org/10.1371/joumal.pntd.0005397
(14.) Graf PC, Chretien JP, Ung L, Gaydos JC, Richards AL. Prevalence of seropositivity to spotted fever group rickettsiae and Anaplasma phagocytophilum in a large, demographically diverse US sample. Clin Infect Dis. 2008;46:70-7. http://dx.doi.org/10.1086/524018
(15.) Trung NV, Hoi LT, Thuong NTH, Toan TK, Huong TTK, Hoa TM, et al. Seroprevalence of scrub typhus, typhus, and spotted fever among rural and urban populations of northern Vietnam. Am J Trop Med Hyg. 2017;96:1084-7. http://dx.doi.org/10.4269/ ajtmh.16-0399
(16.) Henry KM, Jiang J, Rozmajzl PJ, Azad AF, Macaluso KR, Richards AL. Development of quantitative real-time PCR assays to detect Rickettsia typhi and Rickettsia felis, the causative agents of murine typhus and flea-borne spotted fever. Mol Cell Probes. 2007;21:17-23. http://dx.doi.org/10.1016/j.mcp.2006.06.002
(17.) Jiang J, Chan T-C, Temenak JJ, Dasch GA, Ching W-M, Richards AL. Development of a quantitative real-time polymerase chain reaction assay specific for Orientia tsutsugamushi. Am J Trop Med Hyg. 2004;70:351-6. http://dx.doi.org/10.4269/ajtmh.2004.70.351
(18.) Jiang J, Stromdahl EY, Richards AL. Detection of Rickettsia parkeri and Candidatus Rickettsia andeanae in Amblyomma maculatum Gulf Coast ticks collected from humans in the United States. Vector-Borne Zoonotic Dis. 2012;12:175-82. http://dx.doi.org/10.1089/vbz.2011.0614
(19.) Wright CL, Nadolny RM, Jiang J, Richards AL, Sonenshine DE, Gaff HD, et al. Rickettsia parkeri in Gulf Coast ticks, southeastern Virginia, USA. Emerg Infect Dis. 2011;17:896-8. http://dx.doi.org/ 10.3201/eid1705.101836
(20.) Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B. 1995;57:289-300. http://dx.doi.org/10.1111/j.2517-6161.1995. tb02031.x
(21.) Strickman D, Tanskul P, Eamsila C, Kelly DJ. Prevalence of antibodies to rickettsiae in the human population of suburban Bangkok. Am J Trop Med Hyg. 1994;51:149-53. http://dx.doi.org/ 10.4269/ajtmh.1994.51.149
(22.) Kramme S, Van An L, Khoa ND, Van Trin L, Tannich E, Rybniker J, et al. Orientia tsutsugamushi bacteremia and cytokine levels in Vietnamese scrub typhus patients. J Clin Microbiol. 2009;47:586-9. http://dx.doi.org/10.1128/JCM.00997-08
(23.) Luce-Fedrow A, Mullins K, Kostik AP, St John HK, Jiang J, Richards AL. Strategies for detecting rickettsiae and diagnosing rickettsial diseases. Future Microbiol. 2015;10:537-64. http://dx.doi.org/10.2217/fmb.14.141
(24.) Phongmany S, Rolain JM, Phetsouvanh R, Blacksell SD, Soukkhaseum V, Rasachack B, et al. Rickettsial infections and fever, Vientiane, Laos. Emerg Infect Dis. 2006;12:256-62. http://dx.doi.org/10.3201/eid1202.050900
(25.) Silpapojakul K, Varachit B, Silpapojakul K. Paediatric scrub typhus in Thailand: a study of 73 confirmed cases. Trans R Soc Trop Med Hyg. 2004;98:354-9. http://dx.doi.org/10.1016/ j.trstmh.2003.10.011
(26.) Sonthayanon P, Chierakul W, Wuthiekanun V, Blacksell SD, Pimda K, Suputtamongkol Y, et al. Rapid diagnosis of scrub typhus in rural Thailand using polymerase chain reaction. Am J Trop Med Hyg. 2006;75:1099-102. http://dx.doi.org/10.4269/ ajtmh.2006.75.1099
(27.) Kim DM, Kim HL, Park CY, Yang TY, Lee JH, Yang JT, et al. Clinical usefulness of eschar polymerase chain reaction for the diagnosis of scrub typhus: a prospective study. Clin Infect Dis. 2006;43:1296-300. http://dx.doi.org/10.1086/508464
(28.) Liu Y-X, Feng D, Zhang Q, Jia N, Zhao Z-T, De Vlas SJ, et al. Key differentiating features between scrub typhus and hemorrhagic fever with renal syndrome in northern China. Am J Trop Med Hyg. 2007;76:801-5. http://dx.doi.org/10.4269/ ajtmh.2007.76.801
(29.) Taylor AJ, Paris DH, Newton PN. A systematic review of mortality from untreated scrub typhus (Orientia tsutsugamushi). PLoS Negl Trop Dis. 2015;9:e0003971. http://dx.doi.org/10.1371/ journal.pntd.0003971
(30.) Weng SC, Lee HC, Chen JJ, Cheng YJ, Chi H, Lin CY. Eschar: a stepping stone to scrub typhus. J Pediatr 2017;181:320-320 e1. http://dx.doi.org/10.1016/jjpeds.2016.10.084
(31.) Jamil M, Lyngrah KG, Lyngdoh M, Hussain M. Clinical manifestations and complications of scrub typhus: a hospital based study from North Eastern India. J Assoc Physicians India. 2014;62:19-23.
(32.) Ogawa M, Hagiwara T, Kishimoto T, Shiga S, Yoshida Y, Furuya Y, et al. Scrub typhus in Japan: epidemiology and clinical features of cases reported in 1998. Am J Trop Med Hyg. 2002;67:162-5. http://dx.doi.org/10.4269/ajtmh.2002.67.162
(33.) Silpapojakul K, Chupuppakarn S, Yuthasompob S, Varachit B, Chaipak D, Borkerd T, et al. Scrub and murine typhus in children with obscure fever in the tropics. Pediatr Infect Dis J. 1991; 10:200-3. http://dx.doi.org/10.1097/00006454-199103000-00006
(34.) Tsay RW, Chang FY. Serious complications in scrub typhus. J Microbiol Immunol Infect. 1998;31:240-4.
(35.) Tsay RW, Chang FY. Acute respiratory distress syndrome in scrub typhus. QJM. 2002;95:126-8. http://dx.doi.org/10.1093/ qjmed/95.2.126
(36.) Hu M-L, Liu J-W, Wu K-L, Lu S-N, Chiou S-S, Kuo C-H, et al. Short report: Abnormal liver function in scrub typhus. Am J Trop Med Hyg. 2005;73:667-8. http://dx.doi.org/10.4269/ ajtmh.2005.73.667
(37.) Tsai CC, Lay CJ, Ho YH, Wang LS, Chen LK. Intravenous minocycline versus oral doxycycline for the treatment of noncomplicated scrub typhus. J Microbiol Immunol Infect. 2011;44:33-8. http://dx.doi.org/10.1016/j.jmii.2011.01.007
(38.) Watt G, Chouriyagune C, Ruangweerayud R, Watcharapichat P, Phulsuksombati D, Jongsakul K, et al. Scrub typhus infections poorly responsive to antibiotics in northern Thailand. Lancet. 1996;348:86-9. http://dx.doi.org/10.1016/S0140-6736(96)02501-9
(39.) Le-Viet N, Phan DT, Le-Viet N, Trinh S, To M, Raoult D, et al. Dual genotype Orientia tsutsugamushi infection in patient with rash and eschar, Vietnam, 2016. Emerg Infect Dis. 2018;24:1520-3. http://dx.doi.org/10.3201/eid2408.171622
Address for correspondence: Allen L. Richards, Naval Medical Research Center, 503 Robert Grant Ave, Silver Spring, MD 20910-7500, USA; email: email@example.com
Author affiliations: National Hospital for Tropical Diseases, Hanoi, Vietnam (N.V. Trung, L.T. Hoi, V.M. Dien, D.T. Huong, T.M. Hoa, V.N. Lien, N.V. Kinh); Hanoi Medical University, Hanoi (N.V. Trung, L.T. Hoi, P.V. Luan, N.V. Kinh); Oxford University Clinical Research Unit and Wellcome Trust Major Overseas Programme, Hanoi (S.O. Lewycka, M. Choisy, J.E. Bryant, B. Nadjm, H.R. van Doorn); University of Oxford, UK (S.O. Lewycka, B. Nadjm, H.R. van Doorn); Institute of Research for Development, Marseille, France (M. Choisy); Merieux Foundation, Lyon, France (J.E. Bryant); Naval Medical Research Center, Silver Spring, Maryland, USA (A.L. Richards); Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA (A.L. Richards)
Caption: Figure 1. Enrollment flow, qPCR results, and presence of eschar among enrollees in study of rickettsial patients, Vietnam, March 2015-March 2017. NS1, nonstructural protein 1; qPCR, quantitative PCR; SFG, scrub typhus group; SFG, spotted fever group; STG, scrub typhus group; +, positive; -, negative.
Caption: Figure 2. Distribution of 302 rickettsial patients, by province, in northern Vietnam, March 2015-March 2017. A) Provinces of northern Vietnam; inset shows location within Vietnam. B) Number of cases by province. BG, Bac Giang; BK, Bac Kan; BN, Bac Ninh; CB, Cao Bang; DB, Dien Bien; HG, Ha Giang; HB, Hoa Binh; HD, Hai Duong; HN, Ha Nam; HP, Hai Phong; HT, Ha Tinh; HY, Hung Yen; LS, Lang Son; NA, Nghe An; NB, Ninh Binh; ND, Nam Dinh; NHO, Hanoi; PT, Phu Tho; QN, Quang Ninh; SL, Son La; TB, Thai Binh; TH, Thanh Hoa; TN, Thai Nguyen; TQ, Tuyen Quang; VP, Vinh Phuc; YB, Yen Bai.
Table 1. Demographic characteristics for 302 patients enrolled in a study of rickettsial diseases, northern Vietnam, March 2015-March 2017 * Characteristic Value Age, y, median (IQR), range 50 (36-60), 16-89 Sex M 158 (52.3) F 144 (47.7) Admitted from community 97 (32.1) Transferred from other hospital or clinic 205 (67.9) Received antimicrobial drugs before 83 (27.5) admission Residence in rural area 171 (56.6) Farmer 127 (42.1) * Values are no. (%) patients except as indicated. IQR, interquartile range. Table 2. Comparison of signs and symptoms for patients with scrub typhus from Hanoi Province with patients from other provinces, northern Vietnam, March 2015-March 2017 * p value Siqn or symptom Noncorrected Corrected Headache 0.7041 0.9071 Myalgia 0.8773 0.9071 Eye pain 0.7745 0.9071 Nausea 0.7295 0.9071 Vomiting 0.5109 0.9071 Diarrhea 0.8530 0.9071 Abdominal pain 0.2053 0.6676 Throat pain 0.8128 0.9071 Cough 0.0158 0.2194 Rash 0.8683 0.9071 Eschar 0.0219 0.2194 Skin hyperemia 0.3239 0.8098 Congestive conjuctiva 0.9071 0.9071 Lymphadenopathy 0.0590 0.3479 Edema 0.0696 0.3479 Rales 0.6423 0.9071 Resonance from lungs 0.5542 0.9071 Liver enlargement 0.2089 0.6676 Spleen enlargement 0.5725 0.9071 Convulsions 0.2336 0.6676 * n = 115; results use Fisher exact test, expressed in p values and corrected using multiple comparisons and the Benjamini and Hochberg method (20). Table 3. Demographic information, signs and symptoms, and laboratory results for 115 patients with PCR-confirmed scrub typhus or murine typhus, northern Vietnam, March 2015-March 2017 * Category qPCR-positive Scrub typhus, n = 103 Age, y, mean 50.0 [+ or -] 15.8 50.0 [+ or -] 16.5 [+ or -] SD Demographics Sex M 56 (48.7) 46 (44.7) F 59 (51.3) 57 (55.3) Residence Hanoi 44 (38.3) 34 (33.0) Rural area 70 (60.9) 66 (64.1) Illness during summer, 80 (69.6) 72 (69.9) April-August Farmer 57 (49.6) 52 (50.5) Treatment in previous 82 (71.3) 74 (71.8) hospitals Prior antimicrobial 33 (30.3) 32 (33.0) drug treatment, n = 109 Symptoms at illness Headache 92 (80.0) 81 (78.6) Myalgia 81 (69.9) 73 (70.9) Retro-orbital pain 21 (18.3) 18 (17.5) Sore throat 13 (11.3) 13 (12.6) Cough 42 (36.5) 38 (36.9) Nausea 30 (26.1) 28 (27.2) Vomiting 21 (18.4) 21 (2 0.6) Abdominal pain, 12 (10.5) 12 (11.8) n = 114 Diarrhea 18 (15.7) 15 (14.6) Physical signs Congested skin 90 (78.3) 82 (79.6) Conjunctivitis 74 (64.4) 66 (64.1) Eschar 55 (48.8) 55 (53.4) Rash 39 (33.9) 35 (34.0) Lymphadenopathy, 19 (16.7) 19 (18.6) n = 114 Hepatomegaly 11 (9.6) 10 (9.7) Splenomegaly 7 (6.1) 6 (5.8) Edema 14 (12.2) 13 (12.6) Rales 24 (20.9) 22 (21.4) Decreased breath 16 (14.0) 16 (15.7) sounds, n = 114 Convulsion 10 (8.7) 10 (9.7) Laboratory test results Erythrocytes, T/L, 4.28 (3.9-4.72) 4.25 (3.86-4.69) median (IQR) Leukocytes, g/L, 8.73 (6.7-11.1) 9.1 (6.62-11.17) median (IQR) Platelets, g/L, median 123 (66-194) 128 (65-194) (IQR) Platelet <100 g/L 49 (42.6) 43 (41.8) Alanine 102 (90.3) 91 (89.2) aminotransferase >40 IU/L, n = 113 Aspartate 106 (93.8) 95 (93.1) aminotransferase ST >37 IU/L, n = 113 Total bilirubin >17 27 (39.1) 24 (40.0) [micro]mol/L, n = 69 Albumin <32 g/L, 39 (48.8) 36 (50.7) n = 80 Creatinine >120 16 (14.2) 15 (14.9) [micro]mol/L, n = 113 Procalcitonin >0.25 80 (79.2) 69 (77.5) ng/mL, n = 101 C-reactive protein >12 mg 85 (91.4) 75 (90.4) Treatment Doxycycline, n = 114 72 (63.2) 63 (61.8) Chloramphenicol, 2 (1.8) 2 (2.0) n = 114 Doxycycline and 30 (26.3) 28 (27.5) chloramphenicol, n = 114 Albumin transfusion, 12 (10.6) 12 (11.9) n = 113 Respiratory support, 29 (25.7) 27 (26.7) n = 111 Outcomes Fever before 9 (7-11) 9 (7-11) admission, d, median (IQR) Afebrile [paragraph] 37 (50.7) 31 (49.2) [less than or equao to] 72 h after treatment began, n = 73 Median no. days to 3 (3-5) 4 (3-5) afebrile, n = 73 (IQR) Median no. days in 7 (5-10) 7 (5-10) hospital (IQR) Death or palliative 5 (4.4) 5 (4.9) discharge Category Murine typhus, p value ([dagger]) n = 12 Age, y, mean 48.4 [+ or -] 8.6 0.709 ([double dagger]) [+ or -] SD Demographics Sex M 10 (83.3) 0.014# F 2 (16.7) 0.001# Residence Hanoi 10 (83.3) 0.001# Rural area 4 (33.3) 0.059 Illness during summer, 8 (66.7) 1.0 April-August Farmer 5(41.7) 0.762 Treatment in previous 8 (66.7) 0.741 hospitals Prior antimicrobial 1 (8.3) 0.152 drug treatment, n = 109 Symptoms at illness Headache 11 (91.7) 0.513 Myalgia 8 (66.7) 0.769 Retro-orbital pain 3 (25.0) 0.535 Sore throat 0 0.529 Cough 4 (33.3) 1.0 Nausea 2 (16.7) 0.718 Vomiting 0 0.228 Abdominal pain, 0 0.527 n = 114 Diarrhea 3 (25.0) 0.664 Physical signs Congested skin 8 (66.7) 0.290 Conjunctivitis 6 (66.7) 1.0 Eschar 0 0# Rash 4 (33.3) 1.0 Lymphadenopathy, 0 0.212 n = 114 Hepatomegaly 1 (8.3) 1.0 Splenomegaly 1 (8.3) 0.548 Edema 1 (8.3) 1.0 Rales 2 (16.7) 1.0 Decreased breath 0 0.212 sounds, n = 114 Convulsion 0 0.596 Laboratory test results Erythrocytes, T/L, 4.34 (4.16-4.85) 0.392 ([section]) median (IQR) Leukocytes, g/L, 8.14 (6.9-10.2) 0.631 ([section]) median (IQR) Platelets, g/L, median 96 (79.5-196.5) 0.902 ([section]) (IQR) Platelet <100 g/L 6 (50.0) 0.759 Alanine 11 (100.0) 0.597 aminotransferase >40 IU/L, n = 113 Aspartate 11 (100.0) 1.0 aminotransferase ST >37 IU/L, n = 113 Total bilirubin >17 3 (33.3) 1.0 [micro]mol/L, n = 69 Albumin <32 g/L, 3 (33.3) 1.0 n = 80 Creatinine >120 1 (8.3) 1.0 [micro]mol/L, n = 113 Procalcitonin >0.25 11 (91.7) 0.451 ng/mL, n = 101 C-reactive protein >12 mg 10 (100) 0.592 Treatment Doxycycline, n = 114 9 (75.0) 0.839 Chloramphenicol, 0 (0.0) 0.839 n = 114 Doxycycline and 2 (16.7) 0.839 chloramphenicol, n = 114 Albumin transfusion, 0 (0.0) 0.357 n = 113 Respiratory support, 2 (16.7) 0.728 n = 111 Outcomes Fever before 8.5 (5-10) 0.130 ([section]) admission, d, median (IQR) Afebrile [paragraph] 6 (60.0) 0.736 [less than or equao to] 72 h after treatment began, n = 73 Median no. days to 3 (3-5) 0.694 ([section]) afebrile, n = 73 (IQR) Median no. days in 8 (7-8.5) 0.822 ([section]) hospital (IQR) Death or palliative 0 (0.0) 1.0 discharge * Values are no. (%), except as indicated. Bold text indicates statistical significance. IQR, interquartile range. ([dagger]) p value calculated using Fisher exact test, except where noted. ([double dagger]) p value calculated using the analysis of variance test. ([section]) p value calculated using Mann-Whitney test. ([paragraph]) No temperature recorded >37.5[degrees]C over a 24-h period. Note: Bold text indicates statistical significance are indicated with #. Figure 3. Frequency of all enrolled patients and those with confirmed scrub typhus or murine typhus in National Hospital for Tropical Diseases and Bach Mai Hospital, by month, Vietnam, March 2015-March 2017. Total Scrub typhus Murine typhus Jan 7 2 Feb 7 3 1 Mar 17 7 2 Apr 25 8 May 61 24 1 Jun 42 16 6 Jul 50 8 Aug 46 16 Sep 14 2 Oct 20 11 Nov 12 5 Dec 1 1 Note: Table made from bar graph.
|Printer friendly Cite/link Email Feedback|
|Author:||Trung, Nguyen Vu; Hoi, Le Thi; Dien, Vu Minh; Huong, Dang Thi; Hoa, Tran Mai; Lien, Vu Ngoc; Van Lua|
|Publication:||Emerging Infectious Diseases|
|Article Type:||Clinical report|
|Date:||Apr 1, 2019|
|Previous Article:||Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas.|
|Next Article:||Mucosal Leishmaniasis in Travelers with Leishmania braziliensis Complex Returning to Israel.|